Skip to main content

Advertisement

Log in

Role of Esophageal Metal Stents Placement and Combination Therapy in Inoperable Esophageal Carcinoma: A Systematic Review and Meta-analysis

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Introduction

More than 50% of patients with esophageal cancer already have inoperable disease at the time of diagnosis. Controversy surrounds the outcomes of patients with advanced esophageal cancer who receive palliative care by either stent alone or stent plus an additional modality. We set out to perform a systematic review and meta-analysis of studies assessing the use of metal stents as treatment options for symptomatic improvement, survival, and adverse events.

Methods

We searched Embase, MEDLINE, and the Cochrane Central Register of Controlled Trials (CENTRAL) from inception until January 14, 2016, as well as other databases for randomized controlled trials (RCTs) comparing esophageal stent versus either esophageal stent plus brachytherapy, radiotherapy, or chemotherapy. For quality assurance purposes throughout the systematic review, multiple independent extractions were performed, and the process was executed as per the standards of the Cochrane collaboration. Primary outcomes were mean change in dysphagia score, overall survival, and quality of life. Secondary outcomes were adverse events including fever, severe pain, aspiration, fistula, stent migration, perforation, and restenosis.

Results

Eight RCTs enrolling 732 patients were included with three distinct comparisons: stents combination therapy vs stents alone (5 studies, n = 417), stents alone versus brachytherapy alone (2 studies, n = 274), and stents + brachytherapy vs brachytherapy alone (1 study, n = 41). Stents combination therapy was defined as stents plus radiotherapy, chemotherapy, or both. Mean change in dysphagia scores favored stents combination therapy versus stents alone, and the effect was seen in patients surviving longer than 3 months. Stents combination therapy was also associated with a more favorable overall survival. The risks of stent migration, aspiration pneumonia, and restenosis were lower in the stents combination group compared to stents alone, while the risks of severe pain, hemorrhage, and fistula formation were higher. Changes in dysphagia scores and overall survival did not differ significantly in the brachytherapy-alone vs stents-alone comparison. The risk of fistula formation and hemorrhage were higher in the stents-alone group, while the risk of perforation was lower, compared to brachytherapy alone. Quality of life improvements were seen in all treatment groups, but were not pooled in analysis due to differing methods of measurement.

Discussion

While there appears to be no immediate short-term differences, those who live longer than 3 months experience a significant improvement in dysphagia score using a stents combination therapy approach vs stents alone. The combination therapy significantly improves the overall survival as well as showed improvements in quality of life scores. Larger randomized controlled trials are needed to assess improvements in dysphagia score, overall survival, quality of life, and adverse events.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.

    Article  CAS  PubMed  Google Scholar 

  2. Bergquist H, Johnsson A, Hammerlid E, et al. Factors predicting survival in patients with advanced oesophageal cancer: a prospective multicentre evaluation. Aliment Pharmacol Ther. 2008;27:385–395.

    Article  CAS  PubMed  Google Scholar 

  3. Talback M, Rosen M, Stenbeck M, et al. Cancer patient survival in Sweden at the beginning of the third millennium–predictions using period analysis. Cancer Causes Control. 2004;15:967–976.

    Article  PubMed  Google Scholar 

  4. Zhang Y. Epidemiology of esophageal cancer. World J Gastroenterol. 2013;19:5598–5606.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Brierley JD, Oza AM. Radiation and chemotherapy in the management of malignant esophageal strictures. Gastrointest Endosc Clin N Am. 1998;8:451–463.

    CAS  PubMed  Google Scholar 

  6. Amdal CD, Jacobsen AB, Sandstad B, et al. Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomised phase III trial. Radiother Oncol. 2013;107:428–433.

    Article  PubMed  Google Scholar 

  7. Wenger U, Johnsson E, Bergquist H, et al. Health economic evaluation of stent or endoluminal brachytherapy as a palliative strategy in patients with incurable cancer of the oesophagus or gastro-oesophageal junction: results of a randomized clinical trial. Eur J Gastroenterol Hepatol. 2005;17:1369–1377.

    Article  PubMed  Google Scholar 

  8. Dai Y, Li C, Xie Y, et al. Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev. 2014;10:CD005048.

    Google Scholar 

  9. Bergquist H, Wenger U, Johnsson E, et al. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial. Dis Esophagus. 2005;18:131–139.

    Article  CAS  PubMed  Google Scholar 

  10. Steyerberg EW, Homs MY, Stokvis A, et al. Stent placement or brachytherapy for palliation of dysphagia from esophageal cancer: a prognostic model to guide treatment selection. Gastrointest Endosc. 2005;62:333–340.

    Article  PubMed  Google Scholar 

  11. de Vet HCW, Eisinga A, Riphagen II, Aertgeerts B, Pewsner D. Chapter 7: searching for studies. In: Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 0.4 [updated September 2008]. The Cochrane Collaboration; 2008.

  12. Tierney JF, Stewart LA, Ghersi D, et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration: www.cochrane-handbook.org; 2011.

  14. Guyatt GH, Oxman AD, Schunemann HJ, et al. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011;64:380–382.

    Article  PubMed  Google Scholar 

  15. Moher D, Altman DG, Liberati A, et al. PRISMA statement. Epidemiology. 2011;22:128. (author reply 128).

    Article  PubMed  Google Scholar 

  16. Deeks J, Higgins J, Altman D, et al. Chapter 9: analysing data and undertaking meta-analyses. In: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011.

  17. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Sterne JE, Moher D. Chapter 10: addressing reporting biases. In: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011.

  19. Homs MY, Essink-Bot ML, Borsboom GJ, et al. Quality of life after palliative treatment for oesophageal carcinoma—a prospective comparison between stent placement and single dose brachytherapy. Eur J Cancer. 2004;40:1862–1871.

    Article  PubMed  Google Scholar 

  20. Homs MY, Steyerberg EW, Eijkenboom WM, et al. Palliative treatment of esophageal cancer with dysphagia: more favourable outcome from single-dose internal brachytherapy than from the placement of a self-expanding stent; a multicenter randomised study. Ned Tijdschr Geneeskd. 2005;149:2800–2806.

    CAS  PubMed  Google Scholar 

  21. Homs MY, Steyerberg EW, Eijkenboom WM, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet. 2004;364:1497–1504.

    Article  PubMed  Google Scholar 

  22. Zhu HD, Guo JH, Mao AW, et al. Conventional stents versus stents loaded with (125)iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial. Lancet Oncol. 2014;15:612–619.

    Article  CAS  PubMed  Google Scholar 

  23. Zhu HD, Guo JH, Teng GJ. Irradiation vs. conventional self-expandable metal stents for the treatment of unresectable esophageal cancer: a multicenter randomized controlled trial. Cardiovasc Intervent Radiol. 2014;37:S223.

    Google Scholar 

  24. Fu JH, Rong TH, Li XD, et al. Treatment of unresectable esophageal carcinoma by stenting with or without radiochemotherapy. Zhonghua Zhong Liu Za Zhi. 2004;26:109–111.

    PubMed  Google Scholar 

  25. Guo JH, Teng GJ, Zhu GY, et al. Self-expandable esophageal stent loaded with 125I seeds: initial experience in patients with advanced esophageal cancer. Radiology. 2008;247:574–581.

    Article  PubMed  Google Scholar 

  26. Lu B, Wu M, Wu P, et al. Clinical effect and safety of 125I particle stent on treatment of postoperative esophageal stricture for patients with advanced esophageal cancer. Chin J Radiol (China). 2014;48:311–315.

    Google Scholar 

  27. Javed A, Pal S, Dash NR, et al. Palliative stenting with or without radiotherapy for inoperable esophageal carcinoma: a randomized trial. J Gastrointest Cancer. 2012;43:63–69.

    Article  CAS  PubMed  Google Scholar 

  28. Spaander MC, Baron TH, Siersema PD, et al. Esophageal stenting for benign and malignant disease: European society of gastrointestinal endoscopy (ESGE) clinical guideline. Endoscopy. 2016;48:939–948.

    Article  PubMed  Google Scholar 

  29. Kanikowski M, Skowronek J, Kubaszewska M, et al. HDR brachytherapy (HDR-BT) combined with stent placement in palliative treatment of esophageal cancer. J Contemp Brachyther. 2009;1:25–32.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew Lai.

Ethics declarations

Conflict of interest

The authors report no conflict of interest and have followed the ethical adherence guidelines.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 95 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lai, A., Lipka, S., Kumar, A. et al. Role of Esophageal Metal Stents Placement and Combination Therapy in Inoperable Esophageal Carcinoma: A Systematic Review and Meta-analysis. Dig Dis Sci 63, 1025–1034 (2018). https://doi.org/10.1007/s10620-018-4957-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-018-4957-z

Keywords

Navigation